Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Medicinkliniken Sundsv

Sundsvall, 851 86, SwedenNot linked to an institution yet

1closed trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Type 1 diabetes

Closed trials

Completed
A Research Study Looking at How the Use of NovoPen® 6 for Treatment With Tresiba® & Fiasp® Affects the Blood Sugar Level in Patients With Type 1 Diabetes as Part of Local Clinical Practice
NCT05069545· Novo Nordisk A/S· Source

Site data: ClinicalTrials.govUpdated 12 Nov 2026

Report an error

Under construction, not live – Medicinkliniken Sundsv: trial site – Frontlight Research